prikaz prve stranice dokumenta Covid ‐19 Pandemic Effects on Breast Cancer Diagnosis in Croatia: A Population‐ and Study
  Preuzmi
PDF 707.37 KB
Znanstveni rad - Izvorni znanstveni rad
Covid ‐19 Pandemic Effects on Breast Cancer Diagnosis in Croatia: A Population‐ and Study
The Oncologist, (2021); https://doi.org/10.1002/onco.13791
Vrdoljak, Eduard; Balja, Melita Perić; Marušić, Zlatko; Avirović, Manuela; Blažičević, Valerija; Tomasović, Čedna; Čerina, Dora; Bajić, Žarko; Miše, Branka Petrić; Belac-Lovasić, Ingrid; Flam, Josipa; Tomić, Snježana

Citiranost:
,
Citirajte ovaj rad

Vrdoljak, E., Balja, M. P., Marušić, Z., Avirović, M., Blažičević, V., Tomasović, Č. ... Tomić, S. (2021). Covid ‐19 Pandemic Effects on Breast Cancer Diagnosis in Croatia: A Population‐ and Study. The Oncologist. doi: 10.1002/onco.13791

Vrdoljak, Eduard, et al. "Covid ‐19 Pandemic Effects on Breast Cancer Diagnosis in Croatia: A Population‐ and Study." The Oncologist, 2021. https://doi.org/10.1002/onco.13791

Vrdoljak, Eduard, Melita Perić Balja, Zlatko Marušić, Manuela Avirović, Valerija Blažičević, Čedna Tomasović, Dora Čerina, et al. "Covid ‐19 Pandemic Effects on Breast Cancer Diagnosis in Croatia: A Population‐ and Study." The Oncologist (2021). https://doi.org/10.1002/onco.13791

Vrdoljak, E., et al. (2021) 'Covid ‐19 Pandemic Effects on Breast Cancer Diagnosis in Croatia: A Population‐ and Study', The Oncologist. doi: 10.1002/onco.13791

Vrdoljak E, Balja MP, Marušić Z, Avirović M, Blažičević V, Tomasović Č, i sur.. Covid ‐19 Pandemic Effects on Breast Cancer Diagnosis in Croatia: A Population‐ and Study. The Oncologist [Internet]. 15.04.2021. [pristupljeno 04.04.2025.]. doi: 10.1002/onco.13791

E. Vrdoljak, et al., "Covid ‐19 Pandemic Effects on Breast Cancer Diagnosis in Croatia: A Population‐ and Study", The Oncologist, Travanj 2021. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:188904. [Citirano: 04.04.2025.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:188904
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Covid ‐19 Pandemic Effects on Breast Cancer Diagnosis in Croatia: A Population‐ and Study
AutorEduard Vrdoljak
AutorMelita Perić Balja
AutorZlatko Marušić
AutorManuela Avirović
AutorValerija Blažičević
AutorČedna Tomasović
AutorDora Čerina
AutorŽarko Bajić
AutorBranka Petrić Miše
AutorIngrid Belac-Lovasić
AutorJosipa Flam
AutorSnježana Tomić
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za onkologiju i radioterapiju)
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za opću patologiju i patološku anatomiju)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Sažetak (engleski)
Background: Our objective was to assess the effects of COVID-19 antiepidemic measures and subsequent changes in the function of the health care system on the number of newly diagnosed breast cancers in the Republic of Croatia. Subjects, materials, and methods: We performed a retrospective, population- and registry-based study during 2020. The comparator was the number of patients newly diagnosed with breast cancer during 2017, 2018, and 2019. The outcome was the change in number of newly... Više diagnosed breast cancer cases. Results: The average monthly percent change after the initial lockdown measures were introduced was -11.0% (95% confidence interval - 22.0% to 1.5%), resulting in a 24% reduction of the newly diagnosed breast cancer cases in Croatia during April, May, and June compared with the same period of 2019. However, during 2020, only 1% fewer new cases were detected than in 2019, or 6% fewer than what would be expected based on the linear trend during 2017-2019. Conclusion: It seems that national health care system measures for controlling the spread of COVID-19 had a detrimental effect on the number of newly diagnosed breast cancer cases in Croatia during the first lockdown. As it is not plausible to expect an epidemiological change to occur at the same time, this may result in later diagnosis, later initiation of treatment, and less favorable outcomes in the future. However, the effect weakened after the first lockdown and COVID-19 control measures were relaxed, and it has not reoccurred during the second COVID-19 wave. Although the COVID-19 lockdown affected the number of newly diagnosed breast cancers, the oncology health care system has shown resilience and compensated for these effects by the end of 2020. Implications for practice: It is possible to compensate for the adverse effects of COVID-19 pandemic control measures on breast cancer diagnosis relatively promptly, and it is of crucial importance to do it as soon as possible. Moreover, as shown by this study's results on the number of newly diagnosed breast cancer cases during the second wave of the pandemic, these adverse effects are preventable to a non-negligible extent. Sakrij dio sažetka
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objavePrihvaćen za objavljivanje
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeZavršna verzija rukopisa prihvaćena za objavljivanje (postprint)
Naslov časopisaThe Oncologist
p-ISSN1083-7159
e-ISSN1549-490X
DOIhttps://doi.org/10.1002/onco.13791
URN:NBNurn:nbn:hr:184:188904
Datum objave publikacije2021-04-15
URL dokumentahttps://onlinelibrary.wiley.com/doi/10.1002/onco.13791
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Datum isteka embarga: 2021-10-19
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2021-04-19 17:36:54
accessibility

closePristupačnostrefresh

Ako želite spremiti trajne postavke, kliknite Spremi, ako ne - vaše će se postavke poništiti kad zatvorite preglednik.